Uncategorized
Back from the dead? GE and Synchrony surprise the markets
admin | February 1, 2019
This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors. This material does not constitute research.
Perhaps it is only a coincidence but GE and its one-time captive credit card business bounced in debt and equity market valuations this week on the heels of better-than-expected 4Q18 results with more optimistic outlooks. Nevertheless, a more defensive view should be maintained on both credits and opportunities taken to reduce positions in each in the face of better buying.
General Electric posted mixed results for 4Q18 with revenues that were lower than expected, though the $33.3 billion was up 5% year-over-year, driven by higher GE Capital revenues. The industrial division revenues were definitely under pressure, with the biggest weakness in the power division where revenues of $3.0 billion were down 29% year-over-year. That decline was slightly offset by higher renewable energy revenues, and still solid aviation revenues of $3.2 billion were up 13% year-over-year. The healthcare business, which is still in question on how it will be monetized by GE, posted 4Q18 revenues of $3.3 billion, or 4% higher year-over-year. This will remain a key component of GE’s valuation issue as the better the healthcare division performs, the higher the proceeds from a sale will be to reduce the remaining leverage of GE. And herein lies the reason for the bump in GE bonds this week: expected improvements in pro forma leverage when the restructuring is completed in the next couple years. Given that execution risk is still a material factor, the current market momentum presents an opportunity to reduce exposure across the credit curve in GE bonds. Perhaps the biggest beneficiaries in the recent trading sessions have been the GE 5.00% NC21 perpetual notes. These preferred securities are now in the $88.00 context after having been down in the low-70s in December. It is unlikely that GE will redeem these notes at the first call date, and depending on the effectiveness of the restructuring of the company the notes are all the more risky given the non-cumulative perpetual nature.
Synchrony (SYF: nr/BBB-/BBB-) got a meaningful lift in the debt and equity markets this week following the 4Q18 results – with good earnings of $783 million, underscored by solid loan growth, higher purchase volume and net interest income that rose 11% year-over-year. Investor optimism increased on the news that SYF renewed its Sam’s Club card agreement, along with similar card agreements with Amazon and Mohawk. This otherwise mundane detail is actually important given the negative reaction in 2018 investors had to the loss of the Walmart card partnership, which was acquired by Capital One. That card partnership was the largest such relationship for SYF and accounted for a large portion of net interest income and fee income. Loss of such key relationships underscores the added facet of risk to the business model beyond that of being an unsecured lender to lower-middle income consumer borrowers in a card segment with adverse credit selection. The market relief may prove to be temporary in nature, as a short-term stop-gap in the riskiest of credit card company business profiles. Nevertheless, it wasn’t only investors who took a bullish view of the Sam’s Club card news, as Fitch also took ratings action on the news with an outlook revision to “stable” from “negative”. Had the BBB-/Neg have resulted in a downgrade, it could have sent SYF bonds into a tailspin on the realization that a split-rated consumer finance company tends to have a short life. Cautious investors may prefer to take gains or lower losses from the recent bump and perhaps revisit the story at cheaper entry points down the road.
This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.
Important Disclaimers
Copyright © 2024 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.
In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.
The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.
In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.
Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.
